US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Agilent Technologies Inc.

us-stock
To Invest in {{usstockname}}
us-stock
$149.26 0.003(0.3%) A at 04 Dec 2025 04:24 PM Diagnostics & Research
Lowest Today 149.11
Highest Today 151.43
Today’s Open 150.48
Prev. Close 148.81
52 Week High 160.27
52 Week Low 96.03
Day’s Range: Low 149.11 High 151.43
52-Week Range: Low 96.03 High 160.27
1 day return -
1 Week return -2.66
1 month return +2.09
3 month return +16.19
6 month return +29.85
1 year return +6.47
3 year return -2.25
5 year return +29.69
10 year return -

Institutional Holdings

Vanguard Total Stock Mkt Idx Inv 3.16

Vanguard 500 Index Investor 2.49

Vanguard Mid Cap Index Institutional 2.24

T. Rowe Price US Mid-Cap Growth Equity 1.37

T. Rowe Price Mid-Cap Growth 1.36

Fidelity 500 Index 1.27

SPDR® S&P 500® ETF 1.22

iShares Core S&P 500 ETF 1.21

Vanguard Health Care Inv 1.17

VanEck Morningstar Wide Moat 0.90

Vanguard Value Index Inv 0.89

VanEck Morningstar Wide Moat ETF 0.86

Vanguard Mid-Cap Growth ETF 0.84

Impax Leaders Strategy Composite 0.79

MFS International Intrinsic Value A 0.79

The Health Care Select Sector SPDR® ETF 0.69

MFS Large Cap Growth Equity 0.66

MFS Massachusetts Inv Gr Stk A 0.65

Pictet-Water I EUR 0.64

DWS Vermögensbildungsfonds I LD 0.62

Balyasny Asset Management LLC 0.46

Market Status

Strong Buy: 9

Buy: 2

Hold: 9

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 42187.70 M

PB Ratio 6.3027

PE Ratio 32.6338

Enterprise Value 44051.46 M

Total Assets 12727.00 M

Volume 2163067

Company Financials

Annual Revenue FY25:6948000000 6948.0M, FY24:6510000000 6510.0M, FY23:6833000000 6833.0M, FY22:6848000000 6848.0M, FY21:6319000000 6319.0M

Annual Profit FY25:3643000000 3643.0M, FY24:3535000000 3535.0M, FY23:3465000000 3465.0M, FY22:3722000000 3722.0M, FY21:3407000000 3407.0M

Annual Net worth FY25:1303000000 1303.0M, FY24:1289000000 1289.0M, FY23:1240000000 1240.0M, FY22:1254000000 1254.0M, FY21:1210000000 1210.0M

Quarterly Revenue Q4/2025:1861000000 1861.0M, Q3/2025:1738000000 1738.0M, Q2/2025:1668000000 1668.0M, Q1/2025:1681000000 1681.0M, Q4/2024:1701000000 1701.0M

Quarterly Profit Q4/2025:964000000 964.0M, Q3/2025:914000000 914.0M, Q2/2025:866000000 866.0M, Q1/2025:899000000 899.0M, Q4/2024:916000000 916.0M

Quarterly Net worth Q4/2025:434000000 434.0M, Q3/2025:336000000 336.0M, Q2/2025:215000000 215.0M, Q1/2025:318000000 318.0M, Q4/2024:351000000 351.0M

Fund house & investment objective

Company Information Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Organisation Diagnostics & Research

Employees 18000

Industry Diagnostics & Research

CEO Mr. Padraig McDonnell

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right